<?xml version="1.0" encoding="UTF-8"?>
<ref id="B51-pathogens-09-00432">
 <label>51.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Iversen</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Grebely</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Catlett</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Cunningham</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Dore</surname>
    <given-names>G.J.</given-names>
   </name>
   <name>
    <surname>Maher</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia</article-title>
  <source>Int. J. Drug Policy</source>
  <year>2017</year>
  <volume>47</volume>
  <fpage>77</fpage>
  <lpage>85</lpage>
  <pub-id pub-id-type="doi">10.1016/j.drugpo.2017.05.022</pub-id>
  <pub-id pub-id-type="pmid">28578863</pub-id>
 </element-citation>
</ref>
